Search

everythinglearnresearchcommunity

for

Search:↓

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Early diagnosis and teamwork are crucial for managing ILVASC effectively.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

A man had two rare autoimmune diseases that might be connected.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

AFL is safe and effective for topical drug delivery but needs larger studies and cheaper devices for wider use.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

PLLA injections can cause hair loss and skin issues.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

A rare genetic mutation caused severe symptoms in a 6-year-old girl with mandibuloacral dysplasia type A.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Low-level laser therapy is a safe and effective long-term treatment for hair loss, improving hair density and thickness.

Low-level laser therapy may help with hair loss but needs more research.

Baricitinib helps treat severe hair loss in people over 65.

A 61-year-old Filipino man had a skin condition that looked like another disease, making diagnosis difficult.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

The treatment was not recommended due to limited effectiveness and significant side effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Low-level laser therapy is a safe, painless method that effectively treats acne and improves skin without post-treatment care.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.